JENNIFER SOLIS: Open Payments
NPI 1679173652 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 54 payments from 24 companies in 2025. Trend: 2023 $299 · 2024 $826 · 2025 $1,196
Food & beverage: $1,196
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $194 |
| Merck Sharp & Dohme LLC | 8 | $175 |
| Incyte Corporation | 7 | $167 |
| AstraZeneca Pharmaceuticals LP | 3 | $77 |
| Janssen Biotech, Inc. | 3 | $59 |
| Astellas Pharma US Inc | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $42 |
| Karyopharm Therapeutics Inc. | 2 | $42 |
| Geron Corporation | 2 | $40 |
Products named: KEYTRUDA, JAKAFI, SCEMBLIX, Fabhalta, MONJUVI, XPOVIO, RYTELO, TALVEY.
Industry payments across TX — which companies pay providers there.
